Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 0.6× sales vs its 1.0× historical median P/S.
Fair value ≈ $5.91 · price $3.65 today
Undervalued · 38% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$QIPT: Quipt Home Medical receives final court approval for take-private transaction https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260306043057QIPT&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
4/4: Quipt Home Medical holders approve US$3.65/share cash sale to Kingswood/Forager; court hearing set for March 5, 2026 | View: Shareholder approval locks in a US$3.65 cash exit with limited remaining upside… $QIPT
$QIPT
Current Stock Price: $3.62
Contracts to trade: $2.5 QIPT Mar 20 2026 Call
Entry: $0.40
Exit: $0.58
ROI: 45%
Hold ~31 days
Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
$QIPT Q1 '26 Earnings Results & Recap
Quipt Home Medical Corp. reported total revenue of $80,996,000 and an Adjusted EBITDA of $17,812,000 for the three months ended December 31, 2025. The company serviced 210,000 patients and completed 290,000 equipment set-ups or deliveries.
$QIPT Forward momentum is increasingly dictated by operational clarity, as stakeholders scrutinize repeatability across reporting periods. Momentum turns durable only after multiple confirmations.
